nodes	percent_of_prediction	percent_of_DWPC	metapath
Colistimethate—Mental disorder—Sunitinib—pancreatic cancer	0.00396	0.00396	CcSEcCtD
Colistimethate—Malnutrition—Sunitinib—pancreatic cancer	0.00393	0.00393	CcSEcCtD
Colistimethate—Chest pain—Tamoxifen—pancreatic cancer	0.00391	0.00391	CcSEcCtD
Colistimethate—Arthralgia—Tamoxifen—pancreatic cancer	0.00391	0.00391	CcSEcCtD
Colistimethate—Anxiety—Tamoxifen—pancreatic cancer	0.00389	0.00389	CcSEcCtD
Colistimethate—Dysphonia—Doxorubicin—pancreatic cancer	0.00388	0.00388	CcSEcCtD
Colistimethate—Flatulence—Sunitinib—pancreatic cancer	0.00387	0.00387	CcSEcCtD
Colistimethate—Chest pain—Erlotinib—pancreatic cancer	0.00387	0.00387	CcSEcCtD
Colistimethate—Arthralgia—Erlotinib—pancreatic cancer	0.00387	0.00387	CcSEcCtD
Colistimethate—Anxiety—Erlotinib—pancreatic cancer	0.00385	0.00385	CcSEcCtD
Colistimethate—Dysgeusia—Sunitinib—pancreatic cancer	0.00385	0.00385	CcSEcCtD
Colistimethate—Oliguria—Epirubicin—pancreatic cancer	0.00375	0.00375	CcSEcCtD
Colistimethate—Epistaxis—Fluorouracil—pancreatic cancer	0.00374	0.00374	CcSEcCtD
Colistimethate—Connective tissue disorder—Irinotecan—pancreatic cancer	0.00366	0.00366	CcSEcCtD
Colistimethate—Dysarthria—Epirubicin—pancreatic cancer	0.00365	0.00365	CcSEcCtD
Colistimethate—Nervous system disorder—Erlotinib—pancreatic cancer	0.00363	0.00363	CcSEcCtD
Colistimethate—Creatinine increased—Epirubicin—pancreatic cancer	0.00363	0.00363	CcSEcCtD
Colistimethate—Urinary tract disorder—Gemcitabine—pancreatic cancer	0.00358	0.00358	CcSEcCtD
Colistimethate—Connective tissue disorder—Gemcitabine—pancreatic cancer	0.00356	0.00356	CcSEcCtD
Colistimethate—Urethral disorder—Gemcitabine—pancreatic cancer	0.00355	0.00355	CcSEcCtD
Colistimethate—Oliguria—Doxorubicin—pancreatic cancer	0.00347	0.00347	CcSEcCtD
Colistimethate—Cough—Sunitinib—pancreatic cancer	0.00343	0.00343	CcSEcCtD
Colistimethate—Musculoskeletal discomfort—Tamoxifen—pancreatic cancer	0.00341	0.00341	CcSEcCtD
Colistimethate—Convulsion—Sunitinib—pancreatic cancer	0.00341	0.00341	CcSEcCtD
Colistimethate—Dysarthria—Doxorubicin—pancreatic cancer	0.00338	0.00338	CcSEcCtD
Colistimethate—Musculoskeletal discomfort—Erlotinib—pancreatic cancer	0.00338	0.00338	CcSEcCtD
Colistimethate—Paraesthesia—Tamoxifen—pancreatic cancer	0.00336	0.00336	CcSEcCtD
Colistimethate—Immune system disorder—Irinotecan—pancreatic cancer	0.00336	0.00336	CcSEcCtD
Colistimethate—Creatinine increased—Doxorubicin—pancreatic cancer	0.00336	0.00336	CcSEcCtD
Colistimethate—Salivary hypersecretion—Epirubicin—pancreatic cancer	0.00335	0.00335	CcSEcCtD
Colistimethate—Mediastinal disorder—Irinotecan—pancreatic cancer	0.00335	0.00335	CcSEcCtD
Colistimethate—Arthralgia—Sunitinib—pancreatic cancer	0.00335	0.00335	CcSEcCtD
Colistimethate—Chest pain—Sunitinib—pancreatic cancer	0.00335	0.00335	CcSEcCtD
Colistimethate—Dyspnoea—Tamoxifen—pancreatic cancer	0.00334	0.00334	CcSEcCtD
Colistimethate—Dyspnoea—Erlotinib—pancreatic cancer	0.0033	0.0033	CcSEcCtD
Colistimethate—Candida infection—Epirubicin—pancreatic cancer	0.0033	0.0033	CcSEcCtD
Colistimethate—Immune system disorder—Gemcitabine—pancreatic cancer	0.00327	0.00327	CcSEcCtD
Colistimethate—Mediastinal disorder—Gemcitabine—pancreatic cancer	0.00327	0.00327	CcSEcCtD
Colistimethate—Blood urea increased—Epirubicin—pancreatic cancer	0.00326	0.00326	CcSEcCtD
Colistimethate—Decreased appetite—Tamoxifen—pancreatic cancer	0.00326	0.00326	CcSEcCtD
Colistimethate—Gastrointestinal disorder—Tamoxifen—pancreatic cancer	0.00323	0.00323	CcSEcCtD
Colistimethate—Fatigue—Tamoxifen—pancreatic cancer	0.00323	0.00323	CcSEcCtD
Colistimethate—Decreased appetite—Erlotinib—pancreatic cancer	0.00322	0.00322	CcSEcCtD
Colistimethate—Gastrointestinal disorder—Erlotinib—pancreatic cancer	0.0032	0.0032	CcSEcCtD
Colistimethate—Fatigue—Erlotinib—pancreatic cancer	0.0032	0.0032	CcSEcCtD
Colistimethate—Flatulence—Irinotecan—pancreatic cancer	0.00319	0.00319	CcSEcCtD
Colistimethate—Bronchospasm—Docetaxel—pancreatic cancer	0.00316	0.00316	CcSEcCtD
Colistimethate—Nervous system disorder—Sunitinib—pancreatic cancer	0.00315	0.00315	CcSEcCtD
Colistimethate—Salivary hypersecretion—Doxorubicin—pancreatic cancer	0.0031	0.0031	CcSEcCtD
Colistimethate—Candida infection—Doxorubicin—pancreatic cancer	0.00305	0.00305	CcSEcCtD
Colistimethate—Blood urea increased—Doxorubicin—pancreatic cancer	0.00302	0.00302	CcSEcCtD
Colistimethate—Urticaria—Tamoxifen—pancreatic cancer	0.00298	0.00298	CcSEcCtD
Colistimethate—Body temperature increased—Erlotinib—pancreatic cancer	0.00293	0.00293	CcSEcCtD
Colistimethate—Musculoskeletal discomfort—Sunitinib—pancreatic cancer	0.00292	0.00292	CcSEcCtD
Colistimethate—Vertigo—Irinotecan—pancreatic cancer	0.00291	0.00291	CcSEcCtD
Colistimethate—Paraesthesia—Sunitinib—pancreatic cancer	0.00288	0.00288	CcSEcCtD
Colistimethate—Dyspnoea—Sunitinib—pancreatic cancer	0.00286	0.00286	CcSEcCtD
Colistimethate—Cough—Irinotecan—pancreatic cancer	0.00283	0.00283	CcSEcCtD
Colistimethate—Decreased appetite—Sunitinib—pancreatic cancer	0.00279	0.00279	CcSEcCtD
Colistimethate—Gastrointestinal disorder—Sunitinib—pancreatic cancer	0.00277	0.00277	CcSEcCtD
Colistimethate—Fatigue—Sunitinib—pancreatic cancer	0.00277	0.00277	CcSEcCtD
Colistimethate—Hypersensitivity—Tamoxifen—pancreatic cancer	0.00276	0.00276	CcSEcCtD
Colistimethate—Cough—Gemcitabine—pancreatic cancer	0.00275	0.00275	CcSEcCtD
Colistimethate—Epistaxis—Docetaxel—pancreatic cancer	0.0027	0.0027	CcSEcCtD
Colistimethate—Asthenia—Tamoxifen—pancreatic cancer	0.00269	0.00269	CcSEcCtD
Colistimethate—Convulsion—Fluorouracil—pancreatic cancer	0.00269	0.00269	CcSEcCtD
Colistimethate—Arthralgia—Gemcitabine—pancreatic cancer	0.00269	0.00269	CcSEcCtD
Colistimethate—Chest pain—Gemcitabine—pancreatic cancer	0.00269	0.00269	CcSEcCtD
Colistimethate—Asthenia—Erlotinib—pancreatic cancer	0.00266	0.00266	CcSEcCtD
Colistimethate—Chest pain—Fluorouracil—pancreatic cancer	0.00264	0.00264	CcSEcCtD
Colistimethate—Nervous system disorder—Irinotecan—pancreatic cancer	0.00259	0.00259	CcSEcCtD
Colistimethate—Diarrhoea—Tamoxifen—pancreatic cancer	0.00256	0.00256	CcSEcCtD
Colistimethate—Urinary tract disorder—Docetaxel—pancreatic cancer	0.00254	0.00254	CcSEcCtD
Colistimethate—Body temperature increased—Sunitinib—pancreatic cancer	0.00254	0.00254	CcSEcCtD
Colistimethate—Diarrhoea—Erlotinib—pancreatic cancer	0.00254	0.00254	CcSEcCtD
Colistimethate—Connective tissue disorder—Docetaxel—pancreatic cancer	0.00253	0.00253	CcSEcCtD
Colistimethate—Nervous system disorder—Gemcitabine—pancreatic cancer	0.00252	0.00252	CcSEcCtD
Colistimethate—Urethral disorder—Docetaxel—pancreatic cancer	0.00252	0.00252	CcSEcCtD
Colistimethate—Nervous system disorder—Fluorouracil—pancreatic cancer	0.00248	0.00248	CcSEcCtD
Colistimethate—Dizziness—Tamoxifen—pancreatic cancer	0.00248	0.00248	CcSEcCtD
Colistimethate—Dizziness—Erlotinib—pancreatic cancer	0.00245	0.00245	CcSEcCtD
Colistimethate—Vomiting—Tamoxifen—pancreatic cancer	0.00238	0.00238	CcSEcCtD
Colistimethate—Paraesthesia—Irinotecan—pancreatic cancer	0.00237	0.00237	CcSEcCtD
Colistimethate—Hypersensitivity—Sunitinib—pancreatic cancer	0.00236	0.00236	CcSEcCtD
Colistimethate—Rash—Tamoxifen—pancreatic cancer	0.00236	0.00236	CcSEcCtD
Colistimethate—Dermatitis—Tamoxifen—pancreatic cancer	0.00236	0.00236	CcSEcCtD
Colistimethate—Vomiting—Erlotinib—pancreatic cancer	0.00236	0.00236	CcSEcCtD
Colistimethate—Dyspnoea—Irinotecan—pancreatic cancer	0.00236	0.00236	CcSEcCtD
Colistimethate—Somnolence—Irinotecan—pancreatic cancer	0.00235	0.00235	CcSEcCtD
Colistimethate—Blood creatinine increased—Epirubicin—pancreatic cancer	0.00235	0.00235	CcSEcCtD
Colistimethate—Headache—Tamoxifen—pancreatic cancer	0.00235	0.00235	CcSEcCtD
Colistimethate—Musculoskeletal discomfort—Gemcitabine—pancreatic cancer	0.00235	0.00235	CcSEcCtD
Colistimethate—Rash—Erlotinib—pancreatic cancer	0.00234	0.00234	CcSEcCtD
Colistimethate—Dermatitis—Erlotinib—pancreatic cancer	0.00233	0.00233	CcSEcCtD
Colistimethate—Immune system disorder—Docetaxel—pancreatic cancer	0.00232	0.00232	CcSEcCtD
Colistimethate—Headache—Erlotinib—pancreatic cancer	0.00232	0.00232	CcSEcCtD
Colistimethate—Mediastinal disorder—Docetaxel—pancreatic cancer	0.00232	0.00232	CcSEcCtD
Colistimethate—Paraesthesia—Gemcitabine—pancreatic cancer	0.00231	0.00231	CcSEcCtD
Colistimethate—Musculoskeletal discomfort—Fluorouracil—pancreatic cancer	0.00231	0.00231	CcSEcCtD
Colistimethate—Asthenia—Sunitinib—pancreatic cancer	0.0023	0.0023	CcSEcCtD
Colistimethate—Decreased appetite—Irinotecan—pancreatic cancer	0.0023	0.0023	CcSEcCtD
Colistimethate—Dyspnoea—Gemcitabine—pancreatic cancer	0.0023	0.0023	CcSEcCtD
Colistimethate—Somnolence—Gemcitabine—pancreatic cancer	0.00229	0.00229	CcSEcCtD
Colistimethate—Gastrointestinal disorder—Irinotecan—pancreatic cancer	0.00228	0.00228	CcSEcCtD
Colistimethate—Fatigue—Irinotecan—pancreatic cancer	0.00228	0.00228	CcSEcCtD
Colistimethate—Paraesthesia—Fluorouracil—pancreatic cancer	0.00227	0.00227	CcSEcCtD
Colistimethate—Dyspnoea—Fluorouracil—pancreatic cancer	0.00226	0.00226	CcSEcCtD
Colistimethate—Mental disorder—Docetaxel—pancreatic cancer	0.00225	0.00225	CcSEcCtD
Colistimethate—Somnolence—Fluorouracil—pancreatic cancer	0.00225	0.00225	CcSEcCtD
Colistimethate—Malnutrition—Docetaxel—pancreatic cancer	0.00224	0.00224	CcSEcCtD
Colistimethate—Decreased appetite—Gemcitabine—pancreatic cancer	0.00224	0.00224	CcSEcCtD
Colistimethate—Nausea—Tamoxifen—pancreatic cancer	0.00223	0.00223	CcSEcCtD
Colistimethate—Gastrointestinal disorder—Gemcitabine—pancreatic cancer	0.00222	0.00222	CcSEcCtD
Colistimethate—Fatigue—Gemcitabine—pancreatic cancer	0.00222	0.00222	CcSEcCtD
Colistimethate—Nausea—Erlotinib—pancreatic cancer	0.0022	0.0022	CcSEcCtD
Colistimethate—Decreased appetite—Fluorouracil—pancreatic cancer	0.0022	0.0022	CcSEcCtD
Colistimethate—Diarrhoea—Sunitinib—pancreatic cancer	0.0022	0.0022	CcSEcCtD
Colistimethate—Dysgeusia—Docetaxel—pancreatic cancer	0.00219	0.00219	CcSEcCtD
Colistimethate—Gastrointestinal disorder—Fluorouracil—pancreatic cancer	0.00219	0.00219	CcSEcCtD
Colistimethate—Blood creatinine increased—Doxorubicin—pancreatic cancer	0.00217	0.00217	CcSEcCtD
Colistimethate—Asthma—Epirubicin—pancreatic cancer	0.00217	0.00217	CcSEcCtD
Colistimethate—Dizziness—Sunitinib—pancreatic cancer	0.00212	0.00212	CcSEcCtD
Colistimethate—Body temperature increased—Irinotecan—pancreatic cancer	0.00209	0.00209	CcSEcCtD
Colistimethate—Vomiting—Sunitinib—pancreatic cancer	0.00204	0.00204	CcSEcCtD
Colistimethate—Body temperature increased—Gemcitabine—pancreatic cancer	0.00204	0.00204	CcSEcCtD
Colistimethate—Rash—Sunitinib—pancreatic cancer	0.00202	0.00202	CcSEcCtD
Colistimethate—Dermatitis—Sunitinib—pancreatic cancer	0.00202	0.00202	CcSEcCtD
Colistimethate—Urticaria—Fluorouracil—pancreatic cancer	0.00201	0.00201	CcSEcCtD
Colistimethate—Headache—Sunitinib—pancreatic cancer	0.00201	0.00201	CcSEcCtD
Colistimethate—Asthma—Doxorubicin—pancreatic cancer	0.00201	0.00201	CcSEcCtD
Colistimethate—Body temperature increased—Fluorouracil—pancreatic cancer	0.002	0.002	CcSEcCtD
Colistimethate—Cough—Docetaxel—pancreatic cancer	0.00195	0.00195	CcSEcCtD
Colistimethate—Hypersensitivity—Irinotecan—pancreatic cancer	0.00195	0.00195	CcSEcCtD
Colistimethate—Convulsion—Docetaxel—pancreatic cancer	0.00194	0.00194	CcSEcCtD
Colistimethate—Arthralgia—Docetaxel—pancreatic cancer	0.00191	0.00191	CcSEcCtD
Colistimethate—Chest pain—Docetaxel—pancreatic cancer	0.00191	0.00191	CcSEcCtD
Colistimethate—Nausea—Sunitinib—pancreatic cancer	0.00191	0.00191	CcSEcCtD
Colistimethate—Asthenia—Irinotecan—pancreatic cancer	0.0019	0.0019	CcSEcCtD
Colistimethate—Hypersensitivity—Fluorouracil—pancreatic cancer	0.00186	0.00186	CcSEcCtD
Colistimethate—Asthenia—Gemcitabine—pancreatic cancer	0.00185	0.00185	CcSEcCtD
Colistimethate—Epistaxis—Epirubicin—pancreatic cancer	0.00182	0.00182	CcSEcCtD
Colistimethate—Diarrhoea—Irinotecan—pancreatic cancer	0.00181	0.00181	CcSEcCtD
Colistimethate—Nervous system disorder—Docetaxel—pancreatic cancer	0.00179	0.00179	CcSEcCtD
Colistimethate—Diarrhoea—Gemcitabine—pancreatic cancer	0.00176	0.00176	CcSEcCtD
Colistimethate—Dizziness—Irinotecan—pancreatic cancer	0.00175	0.00175	CcSEcCtD
Colistimethate—Diarrhoea—Fluorouracil—pancreatic cancer	0.00173	0.00173	CcSEcCtD
Colistimethate—Urinary tract disorder—Epirubicin—pancreatic cancer	0.00171	0.00171	CcSEcCtD
Colistimethate—Connective tissue disorder—Epirubicin—pancreatic cancer	0.0017	0.0017	CcSEcCtD
Colistimethate—Urethral disorder—Epirubicin—pancreatic cancer	0.0017	0.0017	CcSEcCtD
Colistimethate—Epistaxis—Doxorubicin—pancreatic cancer	0.00169	0.00169	CcSEcCtD
Colistimethate—Vomiting—Irinotecan—pancreatic cancer	0.00168	0.00168	CcSEcCtD
Colistimethate—Dizziness—Fluorouracil—pancreatic cancer	0.00167	0.00167	CcSEcCtD
Colistimethate—Rash—Irinotecan—pancreatic cancer	0.00167	0.00167	CcSEcCtD
Colistimethate—Dermatitis—Irinotecan—pancreatic cancer	0.00166	0.00166	CcSEcCtD
Colistimethate—Musculoskeletal discomfort—Docetaxel—pancreatic cancer	0.00166	0.00166	CcSEcCtD
Colistimethate—Headache—Irinotecan—pancreatic cancer	0.00166	0.00166	CcSEcCtD
Colistimethate—Paraesthesia—Docetaxel—pancreatic cancer	0.00164	0.00164	CcSEcCtD
Colistimethate—Vomiting—Gemcitabine—pancreatic cancer	0.00164	0.00164	CcSEcCtD
Colistimethate—Dyspnoea—Docetaxel—pancreatic cancer	0.00163	0.00163	CcSEcCtD
Colistimethate—Somnolence—Docetaxel—pancreatic cancer	0.00162	0.00162	CcSEcCtD
Colistimethate—Rash—Gemcitabine—pancreatic cancer	0.00162	0.00162	CcSEcCtD
Colistimethate—Dermatitis—Gemcitabine—pancreatic cancer	0.00162	0.00162	CcSEcCtD
Colistimethate—Tinnitus—Epirubicin—pancreatic cancer	0.00162	0.00162	CcSEcCtD
Colistimethate—Headache—Gemcitabine—pancreatic cancer	0.00161	0.00161	CcSEcCtD
Colistimethate—Vomiting—Fluorouracil—pancreatic cancer	0.00161	0.00161	CcSEcCtD
Colistimethate—Rash—Fluorouracil—pancreatic cancer	0.0016	0.0016	CcSEcCtD
Colistimethate—Dermatitis—Fluorouracil—pancreatic cancer	0.00159	0.00159	CcSEcCtD
Colistimethate—Decreased appetite—Docetaxel—pancreatic cancer	0.00159	0.00159	CcSEcCtD
Colistimethate—Headache—Fluorouracil—pancreatic cancer	0.00159	0.00159	CcSEcCtD
Colistimethate—Urinary tract disorder—Doxorubicin—pancreatic cancer	0.00158	0.00158	CcSEcCtD
Colistimethate—Gastrointestinal disorder—Docetaxel—pancreatic cancer	0.00158	0.00158	CcSEcCtD
Colistimethate—Connective tissue disorder—Doxorubicin—pancreatic cancer	0.00158	0.00158	CcSEcCtD
Colistimethate—Fatigue—Docetaxel—pancreatic cancer	0.00158	0.00158	CcSEcCtD
Colistimethate—Urethral disorder—Doxorubicin—pancreatic cancer	0.00157	0.00157	CcSEcCtD
Colistimethate—Nausea—Irinotecan—pancreatic cancer	0.00157	0.00157	CcSEcCtD
Colistimethate—Immune system disorder—Epirubicin—pancreatic cancer	0.00157	0.00157	CcSEcCtD
Colistimethate—Mediastinal disorder—Epirubicin—pancreatic cancer	0.00156	0.00156	CcSEcCtD
Colistimethate—Nausea—Gemcitabine—pancreatic cancer	0.00153	0.00153	CcSEcCtD
Colistimethate—Mental disorder—Epirubicin—pancreatic cancer	0.00152	0.00152	CcSEcCtD
Colistimethate—Malnutrition—Epirubicin—pancreatic cancer	0.00151	0.00151	CcSEcCtD
Colistimethate—Nausea—Fluorouracil—pancreatic cancer	0.0015	0.0015	CcSEcCtD
Colistimethate—Tinnitus—Doxorubicin—pancreatic cancer	0.0015	0.0015	CcSEcCtD
Colistimethate—Flatulence—Epirubicin—pancreatic cancer	0.00149	0.00149	CcSEcCtD
Colistimethate—Dysgeusia—Epirubicin—pancreatic cancer	0.00148	0.00148	CcSEcCtD
Colistimethate—Immune system disorder—Doxorubicin—pancreatic cancer	0.00145	0.00145	CcSEcCtD
Colistimethate—Mediastinal disorder—Doxorubicin—pancreatic cancer	0.00145	0.00145	CcSEcCtD
Colistimethate—Body temperature increased—Docetaxel—pancreatic cancer	0.00144	0.00144	CcSEcCtD
Colistimethate—Mental disorder—Doxorubicin—pancreatic cancer	0.00141	0.00141	CcSEcCtD
Colistimethate—Malnutrition—Doxorubicin—pancreatic cancer	0.0014	0.0014	CcSEcCtD
Colistimethate—Flatulence—Doxorubicin—pancreatic cancer	0.00138	0.00138	CcSEcCtD
Colistimethate—Dysgeusia—Doxorubicin—pancreatic cancer	0.00137	0.00137	CcSEcCtD
Colistimethate—Vertigo—Epirubicin—pancreatic cancer	0.00136	0.00136	CcSEcCtD
Colistimethate—Hypersensitivity—Docetaxel—pancreatic cancer	0.00135	0.00135	CcSEcCtD
Colistimethate—Cough—Epirubicin—pancreatic cancer	0.00132	0.00132	CcSEcCtD
Colistimethate—Asthenia—Docetaxel—pancreatic cancer	0.00131	0.00131	CcSEcCtD
Colistimethate—Convulsion—Epirubicin—pancreatic cancer	0.00131	0.00131	CcSEcCtD
Colistimethate—Arthralgia—Epirubicin—pancreatic cancer	0.00129	0.00129	CcSEcCtD
Colistimethate—Chest pain—Epirubicin—pancreatic cancer	0.00129	0.00129	CcSEcCtD
Colistimethate—Anxiety—Epirubicin—pancreatic cancer	0.00128	0.00128	CcSEcCtD
Colistimethate—Vertigo—Doxorubicin—pancreatic cancer	0.00126	0.00126	CcSEcCtD
Colistimethate—Diarrhoea—Docetaxel—pancreatic cancer	0.00125	0.00125	CcSEcCtD
Colistimethate—Cough—Doxorubicin—pancreatic cancer	0.00122	0.00122	CcSEcCtD
Colistimethate—Convulsion—Doxorubicin—pancreatic cancer	0.00121	0.00121	CcSEcCtD
Colistimethate—Nervous system disorder—Epirubicin—pancreatic cancer	0.00121	0.00121	CcSEcCtD
Colistimethate—Dizziness—Docetaxel—pancreatic cancer	0.00121	0.00121	CcSEcCtD
Colistimethate—Arthralgia—Doxorubicin—pancreatic cancer	0.00119	0.00119	CcSEcCtD
Colistimethate—Chest pain—Doxorubicin—pancreatic cancer	0.00119	0.00119	CcSEcCtD
Colistimethate—Anxiety—Doxorubicin—pancreatic cancer	0.00119	0.00119	CcSEcCtD
Colistimethate—Vomiting—Docetaxel—pancreatic cancer	0.00116	0.00116	CcSEcCtD
Colistimethate—Rash—Docetaxel—pancreatic cancer	0.00115	0.00115	CcSEcCtD
Colistimethate—Dermatitis—Docetaxel—pancreatic cancer	0.00115	0.00115	CcSEcCtD
Colistimethate—Headache—Docetaxel—pancreatic cancer	0.00114	0.00114	CcSEcCtD
Colistimethate—Musculoskeletal discomfort—Epirubicin—pancreatic cancer	0.00112	0.00112	CcSEcCtD
Colistimethate—Nervous system disorder—Doxorubicin—pancreatic cancer	0.00112	0.00112	CcSEcCtD
Colistimethate—Paraesthesia—Epirubicin—pancreatic cancer	0.00111	0.00111	CcSEcCtD
Colistimethate—Dyspnoea—Epirubicin—pancreatic cancer	0.0011	0.0011	CcSEcCtD
Colistimethate—Somnolence—Epirubicin—pancreatic cancer	0.0011	0.0011	CcSEcCtD
Colistimethate—Nausea—Docetaxel—pancreatic cancer	0.00109	0.00109	CcSEcCtD
Colistimethate—Decreased appetite—Epirubicin—pancreatic cancer	0.00107	0.00107	CcSEcCtD
Colistimethate—Gastrointestinal disorder—Epirubicin—pancreatic cancer	0.00106	0.00106	CcSEcCtD
Colistimethate—Fatigue—Epirubicin—pancreatic cancer	0.00106	0.00106	CcSEcCtD
Colistimethate—Musculoskeletal discomfort—Doxorubicin—pancreatic cancer	0.00104	0.00104	CcSEcCtD
Colistimethate—Paraesthesia—Doxorubicin—pancreatic cancer	0.00102	0.00102	CcSEcCtD
Colistimethate—Dyspnoea—Doxorubicin—pancreatic cancer	0.00102	0.00102	CcSEcCtD
Colistimethate—Somnolence—Doxorubicin—pancreatic cancer	0.00101	0.00101	CcSEcCtD
Colistimethate—Decreased appetite—Doxorubicin—pancreatic cancer	0.000991	0.000991	CcSEcCtD
Colistimethate—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	0.000984	0.000984	CcSEcCtD
Colistimethate—Fatigue—Doxorubicin—pancreatic cancer	0.000983	0.000983	CcSEcCtD
Colistimethate—Urticaria—Epirubicin—pancreatic cancer	0.000979	0.000979	CcSEcCtD
Colistimethate—Body temperature increased—Epirubicin—pancreatic cancer	0.000974	0.000974	CcSEcCtD
Colistimethate—Hypersensitivity—Epirubicin—pancreatic cancer	0.000908	0.000908	CcSEcCtD
Colistimethate—Urticaria—Doxorubicin—pancreatic cancer	0.000906	0.000906	CcSEcCtD
Colistimethate—Body temperature increased—Doxorubicin—pancreatic cancer	0.000901	0.000901	CcSEcCtD
Colistimethate—Asthenia—Epirubicin—pancreatic cancer	0.000884	0.000884	CcSEcCtD
Colistimethate—Diarrhoea—Epirubicin—pancreatic cancer	0.000843	0.000843	CcSEcCtD
Colistimethate—Hypersensitivity—Doxorubicin—pancreatic cancer	0.00084	0.00084	CcSEcCtD
Colistimethate—Asthenia—Doxorubicin—pancreatic cancer	0.000818	0.000818	CcSEcCtD
Colistimethate—Dizziness—Epirubicin—pancreatic cancer	0.000815	0.000815	CcSEcCtD
Colistimethate—Vomiting—Epirubicin—pancreatic cancer	0.000784	0.000784	CcSEcCtD
Colistimethate—Diarrhoea—Doxorubicin—pancreatic cancer	0.00078	0.00078	CcSEcCtD
Colistimethate—Rash—Epirubicin—pancreatic cancer	0.000777	0.000777	CcSEcCtD
Colistimethate—Dermatitis—Epirubicin—pancreatic cancer	0.000776	0.000776	CcSEcCtD
Colistimethate—Headache—Epirubicin—pancreatic cancer	0.000772	0.000772	CcSEcCtD
Colistimethate—Dizziness—Doxorubicin—pancreatic cancer	0.000754	0.000754	CcSEcCtD
Colistimethate—Nausea—Epirubicin—pancreatic cancer	0.000732	0.000732	CcSEcCtD
Colistimethate—Vomiting—Doxorubicin—pancreatic cancer	0.000725	0.000725	CcSEcCtD
Colistimethate—Rash—Doxorubicin—pancreatic cancer	0.000719	0.000719	CcSEcCtD
Colistimethate—Dermatitis—Doxorubicin—pancreatic cancer	0.000718	0.000718	CcSEcCtD
Colistimethate—Headache—Doxorubicin—pancreatic cancer	0.000714	0.000714	CcSEcCtD
Colistimethate—Nausea—Doxorubicin—pancreatic cancer	0.000677	0.000677	CcSEcCtD
